Protect Alzheimer’s Patients from Information Overload
We live in a global society, and within our society terrible things happen. We indirectly face tragedy every day. We’re constantly bombarded by breaking ... Read more
Updates
-
News Alzheimer’s Patient Reverted Back to Earlier Writing Style after Diagnosis, Reveals Analysis of Woman’s Long-term Journals
-
News Oral Anticoagulant Dabigatran Prevented Memory Loss in Mouse Model of Alzheimer’s, Study Shows
-
News Long-term Extension Study of Anavex 2-73, Potential Treatment of Alzheimer’s Dementia, Opens
-
News Nuplazid Significantly Delays Relapses in Dementia-related Psychosis, Phase 3 Study Shows
-
News NDX-1017 Phase 1 Trial Complete, Results Will Be Presented at CTAD Conference, Athira Says
-
News NIA Launches Research Centers to Advance Drug Discovery in Alzheimer’s
-
News $53M NIA Grant Will Test Alzheimer’s Care in Real-world Settings
-
News Carefully Targeting Brain Immune Cells May Help Prevent Amyloid-beta Plaques, Study Suggests
-
News Free Online Series Explores Alzheimer’s, Treatment Challenges and Ways of Lowering Risk
-
News First Alzheimer’s Patients Dosed with PTI-125 in New Phase 2b Clinical Trial
-
News Electromagnetic Device Improves Cognition in Alzheimer’s Patients, Small Study Finds
-
News Phase 3 Trials of Elenbecestat in Early Alzheimer’s Stopped for Lack of Benefit, Eisai and Biogen Say
-
News Alzheimer’s Vaccine Found Safe, Effective in Patients with Mild Forms of the Disease, Phase 2 Study Finds
-
News Bryostatin-1 Fails to Ease Dementia in Moderate-to-Severe Alzheimer’s Patients in Phase 2 Trial
-
News FTC Warns Companies Against Unsubstantiated Advertising of CBD Products for Fibromyalgia
-
News PTI-125 Reduces Neurodegeneration After 28 Days of Treatment, Data Show
-
News ADvance II Study Testing Deep Brain Stimulation in Mild Alzheimer’s Started, Enrollment Ongoing
-
News Diet Directly Affects Gut Bacteria and May Contribute to Alzheimer’s Progression, Pilot Study Suggests
-
News ARPF Set to Host Brain Longevity Therapy Training and Symposium
-
News TREM2 Protein May Slow Memory Impairment in Alzheimer’s, Study Suggests
-
News ATXN1 Gene Tied to Rare Disorder Regulates Key Enzyme in Alzheimer’s
-
News 3D Model Unravels How Beta-amyloid Weakens Brain-Blood Barrier, May Aid in Treatment Discovery
-
News Understanding Protein Aggregation May Aid Quest for Better Alzheimer’s Treatments
-
News Managing Caregiver Stress in AD Essential During Back-to-School Time, AFA Says
-
News Diet Rich in Choline Aids Memory and Lowers Risk of Dementia, Study Suggests
-
News FDG PET Scan More Accurately Assesses Severity of Cognitive Decline in Alzheimer’s, Study Finds
-
News Middle-Age Adults With High Blood Pressure at Greater Risk of Dementia, Study Suggests
-
News Protein Treatment, GRF6019, Seen to Help Maintain Cognition in Alzheimer’s Patients in Phase 2 Trial
-
News Blood Markers May ID People Most Likely to Gain Cognitively with Aerobic Exercise, Study Reports
-
News AC Immune’s Anti-Tau Vaccine ACI-35.030 to Be Tested in Phase 1b/2a Trial
-
News UAFS, Arkansas Senior Residence Use 3D Technology to Aid Recreational Therapy
-
News AZTherapies Completes Enrollment for ALZT-OP1 Trial for Early Alzheimer’s
-
News Chemical Compound Can Restore Neural Function in Familial Alzheimer’s, Study Finds
-
News $47M Federal Grant Adds Brain Imaging to Pivotal Lifestyle Interventions Study
-
News Longeveron Gets $3M Alzheimer’s Association Grant to Continue Stem Cell Study
-
News Carriers of CHRFAM7A gene Less Responsive to Cholinesterase Inhibitors, Study Suggests
-
News Samus Therapeutics Launches Phase 1 Trial of Tau-targeting Therapy
-
News Samumed’s SM07883 Can Prevent Tau-Mediated Neuroinflammation, Neurodegeneration in Mice, Study Shows
-
News Having Close Relatives With Alzheimer’s is Linked to Worse Memory, Study Says
-
News Healthy Lifestyle Choices May Lower Risk of Cognitive Decline and Alzheimer’s Dementia, Research Shows
-
News Therapeutic Inhibitors of LIMK1 May Help Halt Cognitive Decline in Alzheimer’s, Study Suggests
-
News Differences in How Proteins Spread in Brain May Explain Increase in Alzheimer’s Risk With Age, Mouse Study Suggests
-
News MemTrax, An Online Test, Helps Track Cognitive Problems in Alzheimer’s
-
News University of Oklahoma Gets $3.75M Grant to Enhance Dementia Care
-
News Seizures May Reduce Brain Cell Production, Result in Poor Spatial Discrimination, Mouse Study Suggests
-
News Low-Carb Diet May Improve Memory in People with Cognitive Problems, Small Study Suggests
-
News Women Carrying ApoE4 Gene More Susceptible Than Men to Toxic Tau Clumps in Brain, Study Suggests
-
News Having Parent or Sibling with Alzheimer’s Linked to Poorer Verbal, Memory Skills in People Taking ‘MindCrowd’ Test
-
News Antibiotics Altering Gut Bacteria Reduced Alzheimer’s Symptoms, But Only in Male Mice, Study Shows
-
News New Genentech Study to Investigate Familial Alzheimer’s Progression and Response to Crenezumab
-
News 1st U.S. Patient Enrolled in Phase 2a Trial Evaluating Vafidemstat for Alzheimer’s
-
News Vaccine Reduces Tau Tangle Formation, Improves Cognitive Functioning in Alzheimer’s Mouse Model
-
News Presence of Mouth Bacteria Linked to Risk of Alzheimer’s, Study Shows
-
News AxoSim Licenses Mini-Brain Technology to Pursue Therapies for Alzheimer’s, Other Disorders
-
News Host of Activities Planned for Alzheimer’s and Brain Awareness Month
-
News High Levels of ‘Bad’ Cholesterol Linked to Increased Risk of Early-onset Alzheimer’s, Study Suggests
-
News ProMIS’ PMN310 Antibody Candidate Shows Greater Effect, Less Risk Than Other Therapies, According to Data
-
News Alzheimer’s Diagnostics Accelerator Program Awards Nearly $3.5M to Develop Early-detection Methods
-
News Virtual Reality May Improve Quality of Life of Hospitalized Dementia Patients, Study Says
-
News Antibodies That Target Neurotoxic Proteins in Alzheimer’s Are Identified
-
News Early Brain Alterations May Occur Decades Before Onset of First Symptoms, Researchers Say
-
News ADDF Grants $1.5M to Fund U.S. Arm of Phase 2a Trial for Vafidemstat in Alzheimer’s Patients
-
News PRI-002, Oral Therapy Candidate for Alzheimer’s, Deemed Safe in Phase 1 Trial
-
Alzheimer's News, News Investigational Alzheimer’s Therapy NNI-362 Receives FDA Approval to Enter Phase 1 Clinical Studies
-
News 2 Planned Clinical Trials to Test Ways of Preventing Alzheimer’s at Early Stages
-
News Sleep Molecules May Represent a New Blood Biomarker for Earlier Diagnosis, Study Suggests
-
News UNC Launches Training Program to Improve Dementia Patients’ Care
-
News Family Caregivers of Dementia Patients May Benefit from Learning Positive Emotion Skills, Study Suggests
-
News Tetra Launches Phase 2 Trial Testing Treatment to Improve Working Memory in Older Patients
-
News #AANAM – Memantine as Add-on Therapy Seen to Ease Psychosis, Other Advanced Alzheimer’s Symptoms
-
News PALS Uplifts the Spirits of Rare-Disease Patients by Offering Free Flights
-
News Long-term Treatment with Thiazide Diuretics May Lower Risk of Bone, Hip Fractures, Study Suggests
-
News Simple Blood Test May Become Useful Biomarker of Alzheimer’s Progression and Treatment Response, Study Suggests
-
News Researchers Create Human-like Antibody for Treatment of Alzheimer’s, PSP
-
News New Model of Blood-Brain Barrier May Aid in Predicting Therapies Able to Best Treat Patients, Scientists Say
-
News Cognitive Training Improves Reasoning and Memory in Adults with Mild Impairment, Pilot Study Finds
-
News Anti-Inflammatory Naproxen Fails to Prevent Alzheimer’s Progression, Phase 2 Trial Confirms
-
News Toll of Family Caregiving on Health is Much Smaller Than Previously Reported, Study Suggests
-
News New Research Unit at England’s University of East Anglia to Study Possible Link Between Sleep and Dementia
-
News Phase 1 Trial of Alzheimer’s Candidate SM07883 Doses First Participant
-
News Investigational Azeliragon May Lessen Cognitive Decline in Mild Alzheimer’s Disease Patients with Type 2 Diabetes, Analysis Finds
-
News Gantenerumab Continues to Show Promise in Reduction of Amyloid Plaques
-
News 2 Common Heart Disease Treatments May Work to Slow or Prevent Vascular Dementia, UK Study Finds
-
News UB-311 Vaccine Safe in Mild Alzheimer’s Patients, Phase 2a Trial Shows
-
News Antiviral Medicine Could Help Halt Cognitive Decline in Early Alzheimer’s, Preliminary Data Show
-
News AVP-786 Relieves Agitation in Alzheimer’s Patients, Preliminary Phase 3 Trial Results Show
-
News ALZ-101 Vaccine Fares Well in Preclinical Study of Alzheimer’s Fish
-
News Trial Begins Testing Blood-derived GRF6019 Therapy for Severe Alzheimer’s Disease
-
News Biogen and Eisai Halt Phase 3 Trials Testing Aducanumab for Early Alzheimer’s
-
News Combination of 2 Dietary Compounds May Have Benefits for Alzheimer’s Patients, Mouse Study Suggests
-
News Dosing Starts in Phase 2 trial of Bryostatin-1 for Alzheimer’s
-
News Brains of People with Sleep Apnea Show Increased Tau Protein Aggregates
-
News Alzheimer’s Association and Women’s Alzheimer’s Movement Launch Campaign to Highlight Disease’s Impact on Women
-
News Manipulating Brain Cells called Astrocytes May Ease Alzheimer’s Symptoms, Study Finds
-
News Hip Fracture in Older People Without Dementia May Be Sign of Undiagnosed Alzheimer’s
-
News Alzheimer’s Disease Duration and Outcome Vary According to Ethnoracial Groups, Study Finds
-
News Extract from Native California Plant Shows Neuroprotective Ability Against Alzheimer’s, Study Reports
-
News AlzProtect’s Candidate Therapy AZP2006 Well-tolerated in Healthy Volunteers, Phase 1 Trial Shows
-
News Denali–Sanofi Partnership Dosing Alzheimer’s Patients in DNL747 Clinical Trial
-
News Phase 2 Trial of Tau Antibody RO7105705 Recruiting Patients with Moderate Alzheimer’s
-
-
Alzheimer’s Patient Reverted Back to Earlier Writing Style after Diagnosis, Reveals Analysis of Woman’s Long-term Journals
The writing style of a woman’s diary entries over 31 years has given researchers a glimpse into the progression of her cognitive decline from ... Read more -
Oral Anticoagulant Dabigatran Prevented Memory Loss in Mouse Model of Alzheimer’s, Study Shows
Oral treatment over one year with an approved blood thinner called dabigatran prevented memory loss, preserved blood circulation in the brain and reduced the ... Read more -
Long-term Extension Study of Anavex 2-73, Potential Treatment of Alzheimer’s Dementia, Opens
Anavex Life Sciences has launched an extension study — called ATTENTION-AD — to investigate the long-term safety and efficacy of Anavex 2-73 in delaying ... Read more -
These Essential Supplies Make Caregiving a Little Easier
The hardest job becomes easier when the right supplies are on hand. This is especially true with caregiving. Every day is a learning experience. ... Read more
-
Nuplazid Significantly Delays Relapses in Dementia-related Psychosis, Phase 3 Study Shows
Treatment with Nuplazid (pimavanserin) significantly delays time to a psychosis relapse in people with dementia-related disorders such ... -
NDX-1017 Phase 1 Trial Complete, Results Will Be Presented at CTAD Conference, Athira Says
Athira Pharma has completed the Phase 1 trial testing NDX-1017, its lead therapeutic candidate ... -
NIA Launches Research Centers to Advance Drug Discovery in Alzheimer’s
To advance the pipeline for innovative therapeutics in Alzheimer’s (AD), the National Institute on Aging ... -
My Sister’s Breast Cancer Diagnosis Taught Us an Important Lesson About Caregiving
October is Breast Cancer Awareness Month, but what does that have to do with ... -
$53M NIA Grant Will Test Alzheimer’s Care in Real-world Settings
The National Institute on Aging (NIA) has awarded a five-year grant expected to total ... -
Carefully Targeting Brain Immune Cells May Help Prevent Amyloid-beta Plaques, Study Suggests
Therapeutics that target brain immune cells known as microglia may prevent the formation of ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
-
Free Online Series Explores Alzheimer’s, Treatment Challenges and Ways of Lowering Risk
An upcoming and free web-based documentary series explores why efforts to develop an Alzheimer’s therapy are ... -
Addressing Unfair Judgment and Some Misconceptions About Caregiving
It’s easy to pass judgment on others about what they may be doing wrong. ... -
-
-
-
-
Alzheimer’s Vaccine Found Safe, Effective in Patients with Mild Forms of the Disease, Phase 2 Study Finds
AXON Neuroscience’s investigational AADvac1 vaccine against tau protein, a hallmark of Alzheimer’s disease, was ... -
-
-
-
Taking a Look at the Cognitive Assessment Disconnect
In the time that it takes to read the first few paragraphs of this ... -
-
-
ARPF Set to Host Brain Longevity Therapy Training and Symposium
With the goal of warding off Alzheimer’s disease through integrative medicine, the Alzheimer’s Research and ... -
Caregiver Preparation Is Key to Patient Care During a Catastrophe
At the time of this writing, all eyes are on the Eastern Seaboard of ... -
TREM2 Protein May Slow Memory Impairment in Alzheimer’s, Study Suggests
Higher concentrations of a protein produced exclusively by the brain’s immune cells, called TREM2, ... -
ATXN1 Gene Tied to Rare Disorder Regulates Key Enzyme in Alzheimer’s
A gene associated with a rare balance disorder also may be involved in susceptibility ... -
Our Family’s Golden Retriever Is More Than Man’s Best Friend
This week, pet lovers across the United States celebrated National Dog Day to bring ... -
3D Model Unravels How Beta-amyloid Weakens Brain-Blood Barrier, May Aid in Treatment Discovery
A new 3D model using human cells grown on a chip can mimic what ... -
Understanding Protein Aggregation May Aid Quest for Better Alzheimer’s Treatments
Better understanding the mathematics behind how protein clumps form — and how therapies interfere ... -
Managing Caregiver Stress in AD Essential During Back-to-School Time, AFA Says
The strain of caring for someone with Alzheimer’s disease (AD) during the hectic back-to-school ... -
Finding the Motivation to Avoid the ‘Caregiving Slump’
Life doesn’t come to a screeching halt while you care for a person who ... -
Diet Rich in Choline Aids Memory and Lowers Risk of Dementia, Study Suggests
A diet rich in phosphatidylcholine, a form of the choline found in foods like eggs ... -
FDG PET Scan More Accurately Assesses Severity of Cognitive Decline in Alzheimer’s, Study Finds
Compared to regular amyloid imaging, fluorodeoxyglucose positron emission tomography (FDG PET), an imaging technique ... -
Middle-Age Adults With High Blood Pressure at Greater Risk of Dementia, Study Suggests
People with high blood pressure, or hypertension, during midlife are at a greater risk ... -
Caregiving Tasks Fluctuate between Urgent and Necessary
One of the greatest privileges of my life was to care for my mother, ... -
Protein Treatment, GRF6019, Seen to Help Maintain Cognition in Alzheimer’s Patients in Phase 2 Trial
Alkahest’s experimental blood-derived protein GRF6019 helps maintain cognition and function in mild to moderate Alzheimer’s ... -
Blood Markers May ID People Most Likely to Gain Cognitively with Aerobic Exercise, Study Reports
Blood levels of certain molecules— metabolites and amino acids — may help to identify ... -
AC Immune’s Anti-Tau Vaccine ACI-35.030 to Be Tested in Phase 1b/2a Trial
AC Immune is launching a Phase 1b/2a clinical trial to evaluate an investigational anti-tau ... -
Self-talk Your Way to a Positive Outlook
Have you heard the saying, “Talking to yourself is OK as long as you ... -
UAFS, Arkansas Senior Residence Use 3D Technology to Aid Recreational Therapy
To foster the cognitive stimulation of its Alzheimer’s disease (AD) residents, an Arkansas senior ...
Anavex ‘Cautiously Optimistic’ After Noting Cognitive Improvement in Alzheimer’s Treatment
News
Anavex Life Sciences says its Alzheimer’s drug candidate Anavex 2-73 may have a role in treating the disease. Data from a long-term extension trial, although small, indicated that the therapy improved cognitive and functional measures in patients. According to data ... Read more